Simulations Plus, Inc. Overview
Pro stress-test →Simulations Plus is the leading developer of modeling and simulation software for the pharmaceutical and biotechnology industries. The software allows pharmaceutical scientists to predict key potential endpoints and dynamics in silico, reducing R&D costs and enabling better project decisions sooner.
Strategic Profile
Pro stress-test →The company is a provider of advanced software and consulting services that enhance drug discovery, development, research, clinical trial operations, regulatory submissions, and commercialization. Simulations Plus is positioning itself as an AI innovator, hosting an investor day in January 2026 to present new AI product vision and solutions.
Competitive Landscape
Pro stress-test →Main competitors include Certara, Schrödinger, and other specialized biotech software providers. Simulations Plus maintains competitive advantage through integrated software-services model, proprietary simulation algorithms, and established client relationships in pharma/biotech.
Industry Context
Simulations Plus, Inc. operates in Biopharma Software & Computational Biology.
Key facts
Founded: 1996 · Headquarters: Research Triangle Park, NC, US · Revenue: $79.2M